Success Stories: EB-1A Approved for Postdoctoral Researcher in Virginia in the Field of Cancer Biology

Client’s Testimonial:

 

Thanks so much for your help and I will recommend your firm to my friends and on MITBBS.
 


On November 3rd, 2014, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Researcher in the Field of Cancer Biology (Approval Notice)


General Field: Cancer Biology

Position at the Time of Case Filing: Postdoctoral Researcher

Country of Origin: China

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Virginia

Approval Notice Date: November 3rd, 2014

Processing Time: 28 Days (13 Days after Premium Processing Requested)

 


Case Summary:

In this case, the client that we had the opportunity to work with was a Postdoctoral Researcher from China in the field of Cancer Biology.  Her specialized research has focused on improving anticancer treatments through improved drug sensitivity and vaccination success. Her work had resulted in 10 peer-reviewed scientific articles; at the time that her case was filed, her publications had been cited at least 224 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of her work.  She had also reviewed 26 manuscripts for distinctive, internationally-circulated journals.  Her superior level of expertise was confirmed in the following quote from an independent recommender, The results of her studies are extremely compelling. First of all, she clearly showed that Parkin associates with the outer surface of microtubules, and that it increased paclitaxel’s ability to bind microtubules in a dose-dependent manner. Parkin was also found to increase paclitaxel’s promotion of microtubule assembly and stability, multinucleation, and apoptosis, thus rendering breast cancer cells much more sensitive to the drug.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of Cancer Biology, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in 28 days.